.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
Argus Health
McKinsey
Dow
AstraZeneca
Federal Trade Commission
Fish and Richardson
Express Scripts
Queensland Health

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085692

« Back to Dashboard
NDA 085692 describes TRIAMCINOLONE ACETONIDE, which is a drug marketed by Mylan Pharms Inc, Taro, Parnell, Perrigo Israel, Teligent Pharma Inc, Pharmafair, Akorn, Perrigo New York, Alpharma Us Pharms, Glenmark Pharms Ltd, Glenmark Pharms, Watson Labs, G And W Labs Inc, Ambix, Wockhardt Eu Operatn, Wockhardt, Lupin Atlantis, Sandoz Inc, Fougera Pharms, Vintage, Lyne, Topiderm, Perrigo Uk Finco, Riconpharma Llc, Pharmaderm, Morton Grove, G And W Labs, Actavis Mid Atlantic, and Cmp Pharma Inc, and is included in seventy-seven NDAs. It is available from sixty-one suppliers. Additional details are available on the TRIAMCINOLONE ACETONIDE profile page.

The generic ingredient in TRIAMCINOLONE ACETONIDE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for 085692

Pharmacology for NDA: 085692

Medical Subject Heading (MeSH) Categories for 085692

Suppliers and Packaging for NDA: 085692

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL 085692 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0002 0168-0002-15 1 TUBE in 1 CARTON (0168-0002-15) > 15 g in 1 TUBE
TRIAMCINOLONE ACETONIDE
triamcinolone acetonide
CREAM;TOPICAL 085692 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0003 0168-0003-15 1 TUBE in 1 CARTON (0168-0003-15) > 15 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.025%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.5%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.1%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Moodys
Queensland Health
Mallinckrodt
Argus Health
Merck
Fish and Richardson
Farmers Insurance
Novartis
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot